VanEck Associates’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.27M | Buy |
165,959
+19,064
| +13% | +$870K | 0.01% | 684 |
|
|
2025
Q4 | $6.51M | Buy |
146,895
+9,966
| +7% | +$429K | 0.01% | 704 |
|
|
2025
Q3 | $5.78M | Buy |
136,929
+14,316
| +12% | +$577K | 0.01% | 710 |
|
|
2025
Q2 | $4.49M | Buy |
122,613
+8,142
| +7% | +$302K | 0.01% | 766 |
|
|
2025
Q1 | $4.36M | Buy |
114,471
+9,612
| +9% | +$358K | 0.01% | 754 |
|
|
2024
Q4 | $3.97M | Buy |
104,859
+4,714
| +5% | +$188K | 0.01% | 774 |
|
|
2024
Q3 | $4.17M | Buy |
100,145
+13,367
| +15% | +$506K | 0.01% | 705 |
|
|
2024
Q2 | $2.97M | Sell |
86,778
-1,915
| -2% | -$60.3K | ﹤0.01% | 763 |
|
|
2024
Q1 | $2.81M | Buy |
88,693
+2,775
| +3% | +$84.4K | ﹤0.01% | 760 |
|
|
2023
Q4 | $2.63M | Buy |
85,918
+12,228
| +17% | +$392K | ﹤0.01% | 731 |
|
|
2023
Q3 | $2.44M | Buy |
73,690
+3,285
| +5% | +$105K | 0.01% | 708 |
|
|
2023
Q2 | $2.16M | Buy |
70,405
+3,244
| +5% | +$93.7K | ﹤0.01% | 710 |
|
|
2023
Q1 | $1.84M | Buy |
67,161
+3,433
| +5% | +$95.5K | ﹤0.01% | 724 |
|
|
2022
Q4 | $1.78M | Buy |
63,728
+4,888
| +8% | +$147K | ﹤0.01% | 697 |
|
|
2022
Q3 | $1.74M | Sell |
58,840
-29,141
| -33% | -$914K | 0.01% | 681 |
|
|
2022
Q2 | $2.48M | Sell |
87,981
-5,227
| -6% | -$149K | 0.01% | 612 |
|
|
2022
Q1 | $2.9M | Sell |
93,208
-15,324
| -14% | -$452K | 0.01% | 620 |
|
|
2021
Q4 | $3.21M | Buy |
108,532
+28,907
| +36% | +$844K | 0.01% | 607 |
|
|
2021
Q3 | $2.39M | Buy |
79,625
+21,526
| +37% | +$741K | 0.01% | 632 |
|
|
2021
Q2 | $2.11M | Buy |
58,099
+24,800
| +74% | +$921K | 0.01% | 653 |
|
|
2021
Q1 | $1.22M | Sell |
33,299
-3,241
| -9% | -$119K | ﹤0.01% | 715 |
|
|
2020
Q4 | $1.33M | Buy |
36,540
+3,603
| +11% | +$122K | ﹤0.01% | 619 |
|
|
2020
Q3 | $986K | Sell |
32,937
-18,028
| -35% | -$563K | ﹤0.01% | 634 |
|
|
2020
Q2 | $1.51M | Sell |
50,965
-8,434
| -14% | -$250K | 0.01% | 539 |
|
|
2020
Q1 | $1.58M | Buy |
59,399
+3,520
| +6% | +$134K | 0.01% | 494 |
|
|
2019
Q4 | $2.37M | Buy |
55,879
+3,378
| +6% | +$143K | 0.01% | 490 |
|
|
2019
Q3 | $2.19M | Buy |
52,501
+5,165
| +11% | +$201K | 0.01% | 467 |
|
|
2019
Q2 | $1.74M | Buy |
47,336
+1,018
| +2% | +$37.1K | 0.01% | 479 |
|
|
2019
Q1 | $1.77M | Sell |
46,318
-1,363
| -3% | -$50.5K | 0.01% | 478 |
|
|
2018
Q4 | $1.68M | Buy |
47,681
+3,835
| +9% | +$133K | 0.01% | 461 |
|
|
2018
Q3 | $1.44M | Buy |
43,846
+2,425
| +6% | +$77.2K | 0.01% | 515 |
|
|
2018
Q2 | $1.28M | Buy |
+41,421
| New | +$1.18M | 0.01% | 526 |
|
Other funds holding OHI
VPM
VCM
VanEck Associates's OHI Position: Q1 2026 in Review
VanEck Associates increased its Omega Healthcare (OHI) stake by 13% in Q1 2026, buying an estimated $870K and bringing the position to 165,959 shares worth $7.27M. The position accounts for 0.01% of the portfolio, ranked #684.
VanEck Associates first reported a position in OHI in Q2 2018 and has held it in 32 quarters since. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.
- VanEck Associates held 165,959 shares of Omega Healthcare worth $7.27M as of Q1 2026.
- VanEck Associates bought 19,064 Omega Healthcare shares in Q1 2026, an estimated $870K.
- Omega Healthcare made up 0.01% of VanEck Associates's portfolio in Q1 2026, its #684 holding.
- VanEck Associates first reported a position in Omega Healthcare in Q2 2018 and has held it in 32 quarters since.
- 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.